Singapore markets closed

Elevance Health Inc (A58.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
495.50-5.50 (-1.10%)
At close: 08:02AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
6,244,000
5,987,000
5,894,000
6,158,000
4,572,000
-
Depreciation & amortisation
1,614,000
1,745,000
1,675,000
1,302,000
1,154,000
-
Deferred income taxes
-211,000
-602,000
-115,000
342,000
-540,000
-
Stock-based compensation
290,000
289,000
264,000
255,000
283,000
-
Change in working capital
-5,577,000
-535,000
423,000
1,123,000
5,254,000
-
Accounts receivable
-
-
-
-
-
-1,053,000
Accounts payable
1,365,000
1,640,000
824,000
719,000
1,978,000
-
Other working capital
2,296,000
6,765,000
7,247,000
7,277,000
9,667,000
-
Other non-cash items
-
-
-
-
-
2,000
Net cash provided by operating activities
3,570,000
8,061,000
8,399,000
8,364,000
10,688,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,274,000
-1,296,000
-1,152,000
-1,087,000
-1,021,000
-
Acquisitions, net
-1,034,000
-1,552,000
-649,000
-3,476,000
-1,976,000
-
Purchases of investments
-14,896,000
-16,236,000
-24,946,000
-18,669,000
-19,492,000
-
Sales/maturities of investments
12,947,000
13,536,000
22,608,000
14,613,000
16,059,000
-
Other investing activities
-441,000
-24,000
-421,000
-1,019,000
-894,000
-
Net cash used for investing activities
-4,698,000
-5,572,000
-4,560,000
-9,638,000
-7,324,000
-
Cash flows from financing activities
Debt repayment
-561,000
-2,174,000
-3,574,000
-2,494,000
-3,752,000
-
Common stock issued
-
-
-
-
0
0
Common stock repurchased
-2,620,000
-2,676,000
-2,316,000
-1,900,000
-2,700,000
-
Dividends paid
-1,423,000
-1,395,000
-1,229,000
-1,104,000
-954,000
-
Other financing activities
-92,000
-92,000
-52,000
-75,000
-126,000
-
Net cash used provided by (used for) financing activities
-2,786,000
-3,349,000
-1,318,000
423,000
-2,567,000
-
Net change in cash
-3,916,000
-861,000
2,507,000
-861,000
804,000
-
Cash at beginning of period
10,142,000
7,387,000
4,880,000
5,741,000
4,937,000
-
Cash at end of period
6,228,000
6,526,000
7,387,000
4,880,000
5,741,000
-
Free cash flow
Operating cash flow
3,570,000
8,061,000
8,399,000
8,364,000
10,688,000
-
Capital expenditure
-1,274,000
-1,296,000
-1,152,000
-1,087,000
-1,021,000
-
Free cash flow
2,296,000
6,765,000
7,247,000
7,277,000
9,667,000
-